Tripti Gaur, Ph.D.
Institution: AVEO Oncology
Boston, MA, United States
Tripti Gaur is Biomarkers and Companion Diagnostics Lead at AVEO Oncology in Boston, MA, where she provides strategic leadership across biomarker development, patient-selection strategy, companion diagnostics, and clinical biomarker data interpretation for oncology programs. With a career spanning precision medicine, translational research, and bioanalytical and biomarker assay development, she holds deep scientific expertise and cross-functional perspective to the integration of clinical, regulatory, and translational considerations in drug development. Dr. Gaur earned her Ph.D. in Molecular Biology from the University of Delhi, India, following an M.S. in Biochemistry from G.B. Pant University of Agriculture and Technology. She has held senior scientific and leadership roles at AffyImmune Therapeutics, Mustang Bio, CRISPR Therapeutics, Takeda/Shire, and the University of Massachusetts Medical School. Her work advances precision medicine by translating molecular insights into patient-selection approaches across oncology, autoimmune, and rare disease programs.
.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none